Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

A Clinical Aid for Detecting Skin Cancer: The Triage Amalgamated Dermoscopic Algorithm (TADA)

T. Rogers, M. L. Marino, S. W. Dusza, S. Bajaj, R. P. Usatine, M. A. Marchetti and A. A. Marghoob
The Journal of the American Board of Family Medicine November 2016, 29 (6) 694-701; DOI: https://doi.org/10.3122/jabfm.2016.06.160079
T. Rogers
From the Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (TR, MLM, SWD, SB, MAM, AAM); Department of Family and Community Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU).
MFA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. L. Marino
From the Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (TR, MLM, SWD, SB, MAM, AAM); Department of Family and Community Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. W. Dusza
From the Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (TR, MLM, SWD, SB, MAM, AAM); Department of Family and Community Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU).
DrPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Bajaj
From the Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (TR, MLM, SWD, SB, MAM, AAM); Department of Family and Community Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. P. Usatine
From the Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (TR, MLM, SWD, SB, MAM, AAM); Department of Family and Community Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. A. Marchetti
From the Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (TR, MLM, SWD, SB, MAM, AAM); Department of Family and Community Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. A. Marghoob
From the Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (TR, MLM, SWD, SB, MAM, AAM); Department of Family and Community Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX (RPU).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Siegel RL,
    2. Miller KD,
    3. Jemal A
    . Cancer statistics, 2015. CA Cancer J Clin 2015;65:5–29.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Lomas A,
    2. Leonardi-Bee J,
    3. Bath-Hextall F
    . A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166:1069–80.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. McDonald CJ
    . American Cancer Society perspective on the American College of Preventive Medicine's policy statements on skin cancer prevention and screening. CA Cancer J Clin 1998;48:229–31.
    OpenUrlPubMedWeb of Science
  4. 4.↵
    1. Kimball AB,
    2. Resneck JS Jr.
    . The US dermatology workforce: A specialty remains in shortage. J Am Acad Dermatol 2008;59:741–5.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Uhlenhake E,
    2. Brodell R,
    3. Mostow E
    . The dermatology work force: A focus on urban versus rural wait times. J Am Acad Dermatol 2009;61:17–22.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Kirsner RS,
    2. Muhkerjee S,
    3. Federman DG
    . Skin cancer screening in primary care: Prevalence and barriers. J Am Acad Dermatol 1999;41:564–6.
    OpenUrlPubMedWeb of Science
  7. 7.↵
    1. Wise E,
    2. Singh D,
    3. Moore M,
    4. et al
    . Rates of skin cancer screening and prevention counseling by US medical residents. Arch Derm 2009;145:1131–6.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Moore MM,
    2. Geller AC,
    3. Zhang Z,
    4. et al
    . Skin cancer examination teaching in US medical education. Arch Derm 2006;142:439–44.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Robison S,
    2. Kljakovic M,
    3. Barry P
    . Choosing to biopsy or refer suspicious melanocytic lesions in general practice. BMC Fam Pract 2012;13:78.
    OpenUrlPubMed
  10. 10.↵
    1. Vestergaard ME,
    2. Macaskill P,
    3. Holt PE,
    4. Menzies SW
    . Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: A meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008;159:669–76.
    OpenUrlPubMedWeb of Science
  11. 11.↵
    1. Kittler H,
    2. Pehamberger H,
    3. Wolff K,
    4. Binder M
    . Diagnostic accuracy of dermoscopy. Lancet Oncol 2002;3:159–65.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Bafounta ML,
    2. Beauchet A,
    3. Aegerter P,
    4. Saiag P
    . Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Derm 2001;137:1343–50.
    OpenUrlPubMedWeb of Science
  13. 13.↵
    1. Argenziano G,
    2. Soyer HP
    . Dermoscopy of pigmented skin lesions—A valuable tool for early diagnosis of melanoma. Lancet Oncol 2001;2:443–9.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Menzies SW,
    2. Emery J,
    3. Staples M,
    4. et al
    . Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: A sequential intervention trial. Br J Dermatol 2009;161:1270–7.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Westerhoff K,
    2. McCarthy WH,
    3. Menzies SW
    . Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol 2000;143:1016–20.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Argenziano G,
    2. Puig S,
    3. Zalaudek I,
    4. et al
    . Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol 2006;24:1877–82.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Dolianitis C,
    2. Kelly J,
    3. Wolfe R,
    4. Simpson P
    . Comparative performance of 4 dermoscopic algorithms by nonexperts for the diagnosis of melanocytic lesions. Arch Derm 2005;141:1008–14.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Soyer HP,
    2. Argenziano G,
    3. Zalaudek I,
    4. et al
    . Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology 2004;208:27–31.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Luttrell MJ,
    2. McClenahan P,
    3. Hofmann-Wellenhof R,
    4. Fink-Puches R,
    5. Soyer HP
    . Laypersons' sensitivity for melanoma identification is higher with dermoscopy images than clinical photographs. Br J Dermatol 2012;167:1037–41.
    OpenUrlPubMed
  20. 20.↵
    1. Koelink CJ,
    2. Jonkman MF,
    3. Van Der Meer K,
    4. Van Der Heide WK
    . Examination of skin lesions for cancer: Which clinical decision aids and tools are available in general practice? Eur J Dermatol 2014;24:297–304.
    OpenUrl
  21. 21.↵
    1. Argenziano G,
    2. Soyer HP,
    3. Chimenti S,
    4. et al
    . Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet. J Am Acad Dermatol 2003;48:679–93.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Henning JS,
    2. Dusza SW,
    3. Wang SQ,
    4. et al
    . The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy. J Am Acad Dermatol 2007;56:45–52.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Marghoob AA,
    2. Usatine RP,
    3. Jaimes N
    . Dermoscopy for the family physician. Am Fam Physician 2013;88:441–50.
    OpenUrl
  24. 24.↵
    1. Marghoob A,
    2. Braun R,
    3. Malvehy J
    . Atlas of Dermoscopy. 2nd ed. London, UK: Informa Healthcare; 2012.
  25. 25.↵
    1. Lallas A,
    2. Moscarella E,
    3. Longo C,
    4. et al
    . Likelihood of finding melanoma when removing a Spitzoid-looking lesion in patients aged 12 years or older. J Am Acad Dermatol 2015;72:47–53.
    OpenUrl
  26. 26.↵
    1. Argenziano G,
    2. Longo C,
    3. Cameron A,
    4. et al
    . Blue-black rule: A simple dermoscopic clue to recognize pigmented nodular melanoma. Br J Dermatol 2011;165:1251–5.
    OpenUrlPubMed
  27. 27.↵
    1. Balagula Y,
    2. Braun RP,
    3. Rabinovitz HS,
    4. et al
    . The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions. J Am Acad Dermatol 2012;67:194.e191–e8.
    OpenUrl
  28. 28.↵
    1. Zalaudek I,
    2. Kittler H,
    3. Hofmann-Wellenhof R,
    4. et al
    . “White” network in Spitz nevi and early melanomas lacking significant pigmentation. J Am Acad Dermatol 2013;69:56–60.
    OpenUrl
  29. 29.↵
    1. Altamura D,
    2. Menzies SW,
    3. Argenziano G,
    4. et al
    . Dermatoscopy of basal cell carcinoma: Morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol 2010;62:67–75.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Pizzichetta MA,
    2. Talamini R,
    3. Stanganelli I,
    4. et al
    . Amelanotic/hypomelanotic melanoma: Clinical and dermoscopic features. Br J Dermatol 2004;150:1117–24.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Braun RP,
    2. Rabinovitz HS,
    3. Krischer J,
    4. et al
    . Dermoscopy of pigmented seborrheic keratosis: A morphological study. Arch Derm 2002;138:1556–60.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Zaballos P,
    2. Puig S,
    3. Llambrich A,
    4. Malvehy J
    . Dermoscopy of dermatofibromas: A prospective morphological study of 412 cases. Arch Derm 2008;144:75–83.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    National Ambulatory Med Care Survey: 2010 Summary Tables. Available from: http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf. Accessed January 19, 2016.
  34. 34.↵
    1. Koelink CJ,
    2. Kollen BJ,
    3. Groenhof F,
    4. van der Meer K,
    5. van der Heide WK
    . Skin lesions suspected of malignancy: An increasing burden on general practice. BMC Fam Pract 2014;15:29.
    OpenUrl
  35. 35.↵
    1. Geller AC,
    2. Koh HK,
    3. Miller DR,
    4. Clapp RW,
    5. Mercer MB,
    6. Lew RA
    . Use of health services before the diagnosis of melanoma: Implications for early detection and screening. J Gen Intern Med 1992;7:154–7.
    OpenUrlPubMedWeb of Science
  36. 36.↵
    1. Pockney P,
    2. Primrose J,
    3. George S,
    4. et al
    . Recognition of skin malignancy by general practitioners: Observational study using data from a population-based randomised controlled trial. Br J Cancer 2009;100:24–7.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Oliveria SA,
    2. Heneghan MK,
    3. Cushman LF,
    4. Ughetta EA,
    5. Halpern AC
    . Skin cancer screening by dermatologists, family practitioners, and internists: Barriers and facilitating factors. Arch Derm 2011;147:39–44.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. van Rijsingen MC,
    2. van Bon B,
    3. van der Wilt GJ,
    4. Lagro-Janssen AL,
    5. Gerritsen MJ
    . The current and future role of general practitioners in skin cancer care: An assessment of 268 general practitioners. Br J Dermatol 2014;170:1366–8.
    OpenUrl
  39. 39.↵
    1. Zalaudek I,
    2. Argenziano G,
    3. Soyer HP,
    4. et al
    . Three-point checklist of dermoscopy: An open internet study. Br J Dermatol 2006;154:431–7.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 29 (6)
The Journal of the American Board of Family Medicine
Vol. 29, Issue 6
November-December 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Clinical Aid for Detecting Skin Cancer: The Triage Amalgamated Dermoscopic Algorithm (TADA)
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Clinical Aid for Detecting Skin Cancer: The Triage Amalgamated Dermoscopic Algorithm (TADA)
T. Rogers, M. L. Marino, S. W. Dusza, S. Bajaj, R. P. Usatine, M. A. Marchetti, A. A. Marghoob
The Journal of the American Board of Family Medicine Nov 2016, 29 (6) 694-701; DOI: 10.3122/jabfm.2016.06.160079

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Clinical Aid for Detecting Skin Cancer: The Triage Amalgamated Dermoscopic Algorithm (TADA)
T. Rogers, M. L. Marino, S. W. Dusza, S. Bajaj, R. P. Usatine, M. A. Marchetti, A. A. Marghoob
The Journal of the American Board of Family Medicine Nov 2016, 29 (6) 694-701; DOI: 10.3122/jabfm.2016.06.160079
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care
  • Training general practitioners in melanoma diagnosis: a scoping review of the literature
  • Dermoscopy for melanoma detection and triage in primary care: a systematic review
  • Teaching Benign Skin Lesions as a Strategy to Improve the Triage Amalgamated Dermoscopic Algorithm (TADA)
  • Bread and Butter of Family Medicine: Guidelines, Population Screening, Diagnostic Evaluations, and Practice Models
  • Google Scholar

More in this TOC Section

  • Successful Implementation of Integrated Behavioral Health
  • Identifying and Addressing Social Determinants of Health with an Electronic Health Record
  • Integrating Adverse Childhood Experiences and Social Risks Screening in Adult Primary Care
Show more Original Research

Similar Articles

Keywords

  • Algorithms
  • Biopsy
  • Cross-Sectional Studies
  • Dermoscopy
  • Palpation
  • Physicians
  • Family
  • Referral and Consultation
  • Sensitivity and Specificity
  • Skin Neoplasms
  • Triage

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire